checkAd

     148  0 Kommentare AstraZeneca and GSK to Keynote Veeva Summit Connect Europe

    Industry leaders come together to connect, learn, and share experiences in advancing drug development

    BARCELONA, Spain, April 28, 2021 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Dr. Ann E. Taylor, M.D., chief medical officer at AstraZeneca, and Regis Simard, president, pharmaceutical supply chain at GSK, will be featured keynote speakers at the 2021 Veeva R&D and Quality Summit Connect Europe. The one-day online event will feature more than 70 sessions and opportunities to collaborate with industry peers across clinical, quality, regulatory, and safety.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Veeva Systems A!
    Long
    188,41€
    Basispreis
    1,61
    Ask
    × 11,73
    Hebel
    Short
    217,76€
    Basispreis
    1,64
    Ask
    × 11,59
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Veeva Systems

    In a fireside chat, Dr. Taylor will share her perspective on the future of product development and how AstraZeneca drives efficiency and speed in clinical trials. Simard will highlight GSK's journey towards digital quality management, detailing the ways in which quality content and processes have come together to streamline supply chain operations.

    Summit Connect is designed to maximize collaboration and learning, alternating large group sessions with smaller, more intimate discussions. The event is expected to bring together more than 2,000 industry experts to discuss the future of clinical trials and the latest innovations in product development and manufacturing. Featured sessions include:

    • AstraZeneca and BMS sharing insights into regulatory strategies for IDMP preparation.
    • Autolus showcasing its quality modernization to meet the unique needs of personalized medicine.
    • Bionical Emas discussing best practices to implement a unified safety solution for greater pharmacovigilance oversight.  
    • TFS HealthScience explaining how digital is simplifying trial management and enabling patient-centric approaches in studies.
    • Sanofi sharing their vision on data management transformation.
    • UCB on the benefits of connecting quality and regulatory for streamlined variation management and change control.

    "Digital strategies and technologies are reshaping how the industry approaches product development and manufacturing for the benefit of patients," said Rik Van Mol, senior vice president of Veeva Development Cloud. "We're proud of the partnerships we've established with our world-class customers and look forward to bringing them together with industry leaders and experts to advance life sciences towards more connected, efficient operations."

    Seite 1 von 2



    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    AstraZeneca and GSK to Keynote Veeva Summit Connect Europe Industry leaders come together to connect, learn, and share experiences in advancing drug development BARCELONA, Spain, April 28, 2021 /PRNewswire/ - Veeva Systems (NYSE: VEEV) today announced that Dr. Ann E. Taylor, M.D., chief medical officer at …